Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Bollard

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bone Marrow Transplantation|May 16, 2007
T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?A A Kennedy-Nasser, C M Bollard
International Journal of Hematology|May 25, 2001
Gene-marking studies of hematopoietic cellsC M Bollard, H E Heslop, M K Brenner
Expert Opinion on Biological Therapy|December 1, 2001
Gene therapy for paediatric leukaemiaR F Rousseau, C M Bollard, H E Heslop
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2000
The use of central venous catheters (portacaths) in children with haemophiliaC M Bollard, L R Teague, E W Berry, et al.
International Journal of Cancer|October 23, 2001
Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genesC Rossig, C M Bollard, J G Nuchtern, et al.
Bone Marrow Transplantation|September 27, 2005
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)G D Myers, R A Krance, H Weiss, et al.
Bone Marrow Transplantation|April 10, 2007
Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantationG D Myers, C M Bollard, M-F Wu, et al.
Bone Marrow Transplantation|July 28, 2010
Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapyN K El-Mallawany, L Geller, C M Bollard, et al.
Bone Marrow Transplantation|September 10, 2005
Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with AlemtuzumabR Lamba, G Carrum, G D Myers, et al.
Cytotherapy|December 11, 2002
Immune therapy for EBV infections after hemopoietic stem-cell transplantH E Heslop, C M Bollard, S Gottschalk, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bone Marrow Transplantation|May 16, 2007
T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?A A Kennedy-Nasser, C M Bollard
International Journal of Hematology|May 25, 2001
Gene-marking studies of hematopoietic cellsC M Bollard, H E Heslop, M K Brenner
Expert Opinion on Biological Therapy|December 1, 2001
Gene therapy for paediatric leukaemiaR F Rousseau, C M Bollard, H E Heslop
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2000
The use of central venous catheters (portacaths) in children with haemophiliaC M Bollard, L R Teague, E W Berry, et al.
International Journal of Cancer|October 23, 2001
Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genesC Rossig, C M Bollard, J G Nuchtern, et al.
Bone Marrow Transplantation|September 27, 2005
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)G D Myers, R A Krance, H Weiss, et al.
Bone Marrow Transplantation|April 10, 2007
Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantationG D Myers, C M Bollard, M-F Wu, et al.
Bone Marrow Transplantation|July 28, 2010
Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapyN K El-Mallawany, L Geller, C M Bollard, et al.
Bone Marrow Transplantation|September 10, 2005
Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with AlemtuzumabR Lamba, G Carrum, G D Myers, et al.
Cytotherapy|December 11, 2002
Immune therapy for EBV infections after hemopoietic stem-cell transplantH E Heslop, C M Bollard, S Gottschalk, et al.
Pageof 2